| Name | Niranthin |
|---|---|
| Synonyms |
4-Methylenedioxylignan
9'-PentaMethoxy-3 6-[(2R,3R)-3-(3,4-Dimethoxybenzyl)-4-methoxy-2-(methoxymethyl)butyl]-4-methoxy-1,3-benzodioxole 1,3-Benzodioxole,6-[(2R,3R)-4-(3,4-dimethoxyphenyl)-2,3-bis(methoxymethyl)butyl]-4-methoxy-,rel rac-Niranthin 6-[(2R,3R)-3-[(3,4-dimethoxyphenyl)methyl]-4-methoxy-2-(methoxymethyl)butyl]-4-methoxy-1,3-benzodioxole Niranthin-RM 3',4',5,9,9'-PentaMethoxy-3,4-Methylenedioxylignan Niranthin, 10 mM in DMSO Pelass |
| Description | Niranthin, a lignan with a wide spectrum of pharmacological activities. Niranthin is a potent and non-competitive inhibitor of heterodimeric type IB topoisomerase of L. donovani. Niranthin can be used for the research of drug-resistant leishmaniasis treatment[1]. |
|---|---|
| Related Catalog | |
| Target |
Topoisomerase |
| References |
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 559.5±50.0 °C at 760 mmHg |
| Molecular Formula | C24H32O7 |
| Molecular Weight | 432.507 |
| Flash Point | 221.8±30.0 °C |
| Exact Mass | 432.214813 |
| PSA | 64.61000 |
| LogP | 4.40 |
| Vapour Pressure | 0.0±1.5 mmHg at 25°C |
| Index of Refraction | 1.534 |
| Hazard Codes | Xi |
|---|